(+)-Afzelechin(CAS: 2545-00-8)

Regulatory guidelines for (+)-Afzelechin (CAS: 2545-00-8) include GHS classification which categorizes it as a substance of very high concern due to its potential health effects. Under REACH regulations, it requires pre-market registration and evaluation by the European Chemicals Agency (ECHA). FDA and EPA may also have specific requirements for its import, distribution, and use in the United States, focusing on safety and environmental impact.

In synthesis, alternatives to (+)-Afzelechin (CAS: 2545-00-8) may include other flavonoids such as apigenin or luteolin. Isomers like (–)-Afzelechin or related compounds like naringenin can also be considered. Common alternative reagents for synthesis might include hydroxycinnamic acid derivatives or other plant-based compounds with similar structural features.

The market and research trend for (+)-Afzelechin (CAS: 2545-00-8) focuses on its potential use in medical research, particularly in the treatment of inflammatory conditions and cancer. Recent studies highlight its antioxidant and anti-inflammatory properties, driving interest in its therapeutic applications. Market trends indicate increasing demand for natural product extracts rich in (+)-Afzelechin.

Waste containing (+)-Afzelechin (CAS: 2545-00-8) should be collected in appropriate containers and stored separately to prevent contamination. For disposal, professional waste disposal services should be contacted. Incineration or chemical treatment methods can be used to destroy the compound, ensuring compliance with environmental protection laws. Always follow local regulations and safety guidelines when handling and disposing of waste containing (+)-Afzelechin.